(Q34234941)

English

Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

personalization

1 reference

based on heuristic

inferred from title

Antonio Giordano

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Giuseppe Toffoli

object named as

Giuseppe Toffoli

4

0 references

Flavio Rizzolio

2

object named as

Flavio Rizzolio

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Giuseppe Corona

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Journal of Cellular Physiology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

227

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2827-2831

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Sarcosine as a potential prostate cancer biomarker and therapeutic target

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Pharmaco-metabonomic phenotyping and personalized drug treatment

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Metabolomics – the link between genotypes and phenotypes

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Nanostructure-initiator mass spectrometry metabolite analysis and imaging

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

13C high-resolution-magic angle spinning MRS reveals differences in glucose metabolism between two breast cancer xenograft models with different gene expression patterns.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Metabolic phenotyping in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Toxicodynamic effects of ciclosporin are reflected by metabolite profiles in the urine of healthy individuals after a single dose

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Pharmacogenetics, pharmacogenomics, and individualized medicine

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

An integrative approach for identifying a metabolic phenotype predictive of individualized pharmacokinetics of tacrolimus.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Successful translation of pharmacogenetics into the clinic: the abacavir example

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Preliminary assessment of magnetic resonance spectroscopic imaging in predicting treatment outcome in patients with prostate cancer at high risk for relapse

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Chemosensitivity prediction by transcriptional profiling

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

A metabonomic approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

THE METABOLISM OF TUMORS IN THE BODY

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Spectroscopic and statistical methods in metabonomics

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Metabolomics and its practical value in pharmaceutical industry

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Advances in NMR-based biofluid analysis and metabolite profiling

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods

1 reference

https://api.crossref.org/works/10.1002%2FJCP.24003

21 January 2018

Identifiers

10.1002/JCP.24003

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34234941&oldid=1744284272"